Theraly Fibrosis, a TEDCO portfolio company, awarded $3.9 Million SBIR Phase II grant to support the development of TLY012 for Chronic Pancreatitis

Theraly Fibrosis, a preclinical-stage biotechnology company focused on development and commercialization of drugs for various fibrotic diseases today announced the company has been awarded a Small Business Innovation Research (SBIR) Phase II grant by the National Institutes of Health (NIH) in the
LEARN MORE

Datakwip, Frederick-based Company, Internationally Recognized as a Top 50 Startup Working in Construction Technology

Datakwip, a building analytics software company in Frederick, Maryland, was internationally recognized in CEMEX Ventures top 50 most promising start-up companies working in construction technology. CEMEX Ventures, Boston Consulting Group (BCG) and Tracxn recently announced their list of the 50 most
LEARN MORE

TEDCO's Linda Singh adds another post-retirement job as Towson U leader-in-residence

Retired Maj. Gen. Linda L. Singh, former adjutant general of the Maryland National Guard, has joined Towson University as its first leader-in-residence, the university announced Monday.
LEARN MORE

6 People in the BioHealth Capital Region You Should Know In 2020 (to include TEDCO's Linda Singh)

Retired Major General Linda Singh was just appointed as interim Executive Director/Chief Executive Officer (ED/CEO) for TEDCO as of January 2020.
LEARN MORE

New Nanoparticle Therapy Appears More Effective Than Standard Therapy at Treating Aggressive Breast Cancer

Experimental Nanoformulation Outperforms FDA-Approved Treatment for Metastatic Breast Cancer, Increasing Survival in Animal Studies
LEARN MORE

Industry-leading companies & experts, to include TEDCO thought leaders, are presenting at the Phacilitate World Stem Cell Summit

LEARN MORE

The United States Of Venture Capital: The Most Active VC In Each State (including TEDCO's Maryland Venture Fund)

LEARN MORE

TEDCO reopens apps for Maryland startup funding

Maryland Technology Development Corporation (TEDCO) is once again accepting applications from startups seeking investment from several of its funds that were put on hold in the middle of 2019.
LEARN MORE

Adaptive Phage gets $10M from DoD for antibacterial phage therapies

The company is developing phage-based therapies designed to target specific bacteria strains, as contrasted with antibiotics, which target multiple types of bacteria.
LEARN MORE

TEDCO, NIST give four companies funding

The Maryland Technology Development Corp. and the National Institute of Standards and Technology awarded four companies a total of $448,000 to develop NIST-licensed technologies for the market, TEDCO announced Tuesday.
LEARN MORE

RoosterBio, a TEDCO portfolio company, expands facility for second time in 2019

Project will support the increasing global need for “off-the-shelf” cell banks and hMSC bioprocess media products as sales continue to climb.
LEARN MORE

HeMemics Biotechnologies, Inc, a Rockville-based TEDCO portfolio company, received a $2.5 million investment from AMVI Partners

Hememics Biotechnologies Inc. plans to use the investment from AMVI Partners to begin clinical research for FDA submission for its flagship biotech product, a point-of-care panel to test for sexually transmitted diseases
LEARN MORE

Machfu, a TEDCO portfolio company, raises $3.75 million to accelerate industrial IoT

CSL Ventures, Blu Ventures, Texas Ventures and Texas Halo Fund lead investment in Machfu’s technology that securely connects critical assets and sensors to modern web services
LEARN MORE

TEDCO Portfolio Company, CoapTech, in the news

'It was a life saver': New London developed device for feeding tube insertions is a world first
LEARN MORE

CIRM (California Institute for Regenerative Medicine) features Elixirgen Scientific on their blog

LEARN MORE